AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Macsita-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Macsita-M 50/1000 Tablet

Diabetic patients with type 2 mellitus may be prescribed the dual-action Macsita-M 50/1000 Tablet to manage elevated blood glucose. This medication helps mitigate serious diabetic complications, such as renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Macsita-M 50/1000 may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on patient health, glycemic control, and other concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia, a potential side effect when co-administered with insulin or sulfonylureas, requires patient awareness and appropriate management strategies. This medication is not universally suitable. Prior to commencing therapy, patients with pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption should inform their physician. Pregnant or lactating individuals should consult their doctor before initiating treatment. Potential drug interactions necessitate disclosure of all medications to the prescribing physician to ensure patient safety. Alcohol consumption should be minimized due to its potential to further reduce blood glucose levels. Regular monitoring of renal function and blood glucose is essential throughout treatment.

Primary Ingredients of Macsita-M 50/1000 Tablet

No text provided. Please provide the text you want me to rewrite.

Uses of Macsita-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Macsita-M 50/1000 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Macsita-M 50/1000 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Macsita-M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Macsita-M 50/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Macsita-M 50/1000 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Macsita-M 50/1000 Tablet works:

Macsita-M 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Macsita-M 50/1000 Tablets is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Macsita-M 50/1000 tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Macsita-M 50/1000 tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Macsita-M 50/1000 tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Macsita-M 50/1000 tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Macsita-M 50/1000 tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Macsita-M 50/1000 Tablet :

Should you forget a Macsita-M 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Macsita-M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Macsita-M 50/1000 Tablet

Macsita-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged use of Macsita-M 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Macsita-M 50/1000 Tablet may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use may also result in vitamin B12 deficiency.
Macsita-M 50/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Macsita-M 50/1000 (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Macsita-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Macsita-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-M 50/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-M 50/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-M 50/1000 tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Macsita-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Macsita-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Macsita-M 50/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-M 50/1000 (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-M 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary or cognitive issues. To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Macsita-M 50/1000 Tablet
124